Figures & data
Table 1. Characteristics of included participants according to different liver steatosis level, weighted.
Table 2. BP and the prevalence of HTN based on different hepatic steatosis level population settings, weighted.
Table 3. The effect of DII tertiles on BP and HTN in patients with different hepatic steatosis degrees, weighted.
Figure 2. Association of DII with SBP and prevalence of HTN in S0 and S3 subgroup in males. A: Association of DII with SBP in S0 and S3 subgroup in males; B: Association of DII with prevalence of HTN in S0 and S3 subgroup in males.
![Figure 2. Association of DII with SBP and prevalence of HTN in S0 and S3 subgroup in males. A: Association of DII with SBP in S0 and S3 subgroup in males; B: Association of DII with prevalence of HTN in S0 and S3 subgroup in males.](/cms/asset/ed38fd46-8668-4ef6-b88d-2ed28b5c59ad/iann_a_2195203_f0002_c.jpg)
Table 4. Association of DII with BP and HTN in patients with different hepatic steatosis degrees, weighted.
Supplemental Material
Download MS Word (24.4 KB)Data availability statement
Publicly available datasets were analyzed in this study. This data can be found here: www.cdc.gov/nchs/nhanes/.